IL-17A Mediates Early Post-Transplant Lesions after Heterotopic Trachea Allotransplantation in Mice

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lemaître, Philippe H ^a   Vokaer, Benoît ^a   Charbonnier, Louis Marie ^a   Iwakura, Yoichiro ^b   Estenne, Marc ^d   Goldman, Michel ^c   Leo, Oberdan ^a   Remmelink, Myriam ^d   Le Moine, Alain ^a,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF TOKYO   (Japan)

^c Innovative Medicines Initiative   (Belgium)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; INTERLEUKIN 17;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CD4+ T LYMPHOCYTE; CELL STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA DELTA T LYMPHOCYTE; HETEROTOPIC TRACHEA TRANSPLANTATION; ISOGRAFT; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIMARY GRAFT DYSFUNCTION; STEM CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; INTERLEUKIN-17; LUNG TRANSPLANTATION; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REPERFUSION INJURY; TRACHEA; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84880841667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070236     Document Type: Article

References (42)

1. Lodhi SA, Lamb KE, Meier-Kriesche HU, (2011) Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 11: 1226-1235. doi:10.1111/j.1600-6143.2011.03539.x. PubMed: 21564524.
2. Lee JC, Christie JD, (2009) Primary graft dysfunction. Proc Am Thorac Soc 6: 39-46. doi:10.1513/pats.200808-082GO. PubMed: 19131529.
3. Christie JD, Bellamy S, Ware LB, Lederer D, Hadjiliadis D, et al. (2010) Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 29: 1231-1239. doi:10.1016/j.healun.2010.05.013. PubMed: 20655249.
4. Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, et al. (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant 29: 1104-1118. doi:10.1016/j.healun.2010.08.004. PubMed: 20870165.
5. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, et al. (2007) Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 175: 507-513. doi:10.1164/rccm.200608-1079OC. PubMed: 17158279.
6. Estenne M, Hertz MI, (2002) Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166: 440-444. doi:10.1164/rccm.200201-003PP. PubMed: 12186817.
7. Li L, Huang L, Vergis AL, Ye H, Bajwa A, et al. (2010) IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120: 331-342. doi:10.1172/JCI38702. PubMed: 20038794.
8. Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, et al. (2012) Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 59: 420-429. doi:10.1016/j.jacc.2011.10.863. PubMed: 22261166.
9. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY, (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197: 322-332. doi:10.1002/path.1117. PubMed: 12115878.
10. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, et al. (2008) A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205: 3133-3144. doi:10.1084/jem.20081937. PubMed: 19047438.
11. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, et al. (2008) Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 177: 660-668. doi:10.1164/rccm.200612-1901OC. PubMed: 18174545.
12. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, Meyts I, Bullens DM, et al. (2008) The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 8: 1911-1920. doi:10.1111/j.1600-6143.2008.02321.x. PubMed: 18786233.
13. Sharma AK, Lapar DJ, Zhao Y, Li L, Lau CL, et al. (2011) Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 183: 1539-1549. doi:10.1164/rccm.201007-1173OC. PubMed: 21317314.
14. Fan L, Benson HL, Vittal R, Mickler EA, Presson R, et al. (2011) Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 11: 911-922. doi:10.1111/j.1600-6143.2011.03482.x. PubMed: 21521466.
15. Onishi RM, Gaffen SL, (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129: 311-321. doi:10.1111/j.1365-2567.2009.03240.x. PubMed: 20409152.
16. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ, (1993) Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 142: 1945-1951. PubMed: 8506960.
17. Neuringer IP, Aris RM, Burns KA, Bartolotta TL, Chalermskulrat W, et al. (2002) Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant 2: 410-419. doi:10.1034/j.1600-6143.2002.20503.x. PubMed: 12123205.
18. Lemaître PH, Vokaer B, Charbonnier LM, Iwakura Y, Field KA, et al. (2013) Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Am J Transplant 13: 611-620. doi:10.1111/ajt.12067. PubMed: 23331973.
19. Murakawa T, Kerklo MM, Zamora MR, Wei Y, Gill RG, et al. (2005) Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol 174: 3869-3879. PubMed: 15778341.
20. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR, (2004) Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 164: 577-588. doi:10.1016/S0002-9440(10)63147-1. PubMed: 14742263.
21. Doddo JM, Hristopoulos ML, Welsh-Servinsky LE, Tankersley CG, Pearse DB, (2006) Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in mice. J Appl Physiol 100: 1590-1595. doi:10.1152/japplphysiol.00681.2005. PubMed: 16439514.
22. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, et al. (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2: 52-72. PubMed: 20926833.
23. Chen Y, Wood KJ, (2007) Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation 84: 1071-1074. doi:10.1097/01.tp.0000287126.12083.48. PubMed: 17998858.
24. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517. doi:10.1146/annurev.immunol.021908.132710. PubMed: 19132915.
25. Pockley AG, Muthana M, (2005) Heat shock proteins and allograft rejection. Contrib Nephrol 148: 122-134. PubMed: 15912031.
26. Kono H, Fujii H, Ogiku M, Hosomura N, Amemiya H, et al. (2011) Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice. J Immunol 187: 4818-4825. doi:10.4049/jimmunol.1100490. PubMed: 21949019.
27. Fernández FG, Jaramillo A, Chen C, Liu DZ, Tung T, et al. (2004) Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 4: 319-325. doi:10.1111/j.1600-6143.2004.00333.x. PubMed: 14961983.
28. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, et al. (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753. doi:10.1681/ASN.2008111160. PubMed: 19497969.
29. Yang Z, Sharma AK, Linden J, Kron IL, Laubach VE, (2009) CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 137: 695-702. doi:10.1016/j.jtcvs.2008.10.044. PubMed: 19258091.
30. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204: 2803-2812. doi:10.1084/jem.20071397. PubMed: 18025126.
31. Hayday AC, (2009) Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 31: 184-196. doi:10.1016/j.immuni.2009.08.006. PubMed: 19699170.
32. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, et al. (2009) Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15: 946-950. doi:10.1038/nm.1999. PubMed: 19648929.
33. Linfert D, Chowdhry T, Rabb H, (2009) Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 23: 1-10. doi:10.1016/S0955-470X(08)00098-0. PubMed: 19027612.
34. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, et al. (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112: 2101-2110. doi:10.1182/blood-2007-12-126987. PubMed: 18596226.
35. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, et al. (2010) Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299: H1283-H1299. doi:10.1152/ajpheart.00251.2010. PubMed: 20833966.
36. Gaffen SL, (2011) Recent advances in the IL-17 cytokine family. Curr Opin Immunol 23: 613-619. doi:10.1016/j.coi.2011.07.006. PubMed: 21852080.
37. Yang XO, Chang SH, Park H, Nurieva R, Shah B, et al. (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205: 1063-1075. doi:10.1084/jem.20071978. PubMed: 18411338.
38. Vokaer B, Van Rompaey N, Lemaître PH, Lhommé F, Kubjak C, et al. (2010) Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol 185: 3417-3425. doi:10.4049/jimmunol.0903961. PubMed: 20733201.
39. Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, et al. (2011) IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLOS ONE 6: e23185. doi:10.1371/journal.pone.0023185. PubMed: 21858022.
40. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552. doi:10.1084/jem.20092121. PubMed: 20176803.
41. Wynn TA, (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350. doi:10.1084/jem.20110551. PubMed: 21727191.
42. Le Moine A, Goldman M, Abramowicz D, (2002) Multiple pathways to allograft rejection. Transplantation 73: 1373-1381. doi:10.1097/00007890-200205150-00001. PubMed: 12023610.